The "Fast Money" traders give their final trades of the day. » Read More
The "Fast Money" traders give you 5 names to trade as markets continue to hit new highs.
CNBC's Seema Mody looks into various reports of a truck running into a crowd of people celebrating Bastille Day in Nice, France.
CNBC's Eamon Javers reports the latest on the race for the White House including rumors around Trump's VP pick.
The "Fast Money" traders share their final trades of the day.
CNBC's Meg Tirrell reports the latest on Martin Shkreli's legal battle and the "Fast Money" traders weigh in on the biotech sector.
The "Fast Money" trader debate the trade on retailers as the "Pokemon Go" mania could mean good news for malls.
The "Fast Money" traders discuss the fundamentals in the current bull market rally.
The "Fast Money" traders share their first moves for Thursday's market open.
The "Fast Money" traders picked sectors that they thought might be good opportunities.
"Fast Money" trader and food tester Guy Adami makes a visit to New York City's new Kellogg's cereal bar.
Jonathan Stubbs, Citigroup Global & European Equity Strategist, discusses changing his mind on market outlooks since February.
Paul Hickey, Bespoke Investment Group co-founder, gives his views on the Russell 2000 and how small-cap surges could put the broader market on track for bigger gains.
CNBC contributor Mike Khouw looks into the options pits for bearish bets on the homebuilder ETF.
CNBC's Dominic Chu reports on social media apathy surrounding the rally in the markets.
CNBC's Susan Li reports the latest on Yum Brands' China business following its earnings release and the "Fast Money" traders weigh in on the trade.
The "Fast Money" traders give you 4 ways to play the start of earnings season.
The "Fast Money" traders debate the trade on Valeant after former CEO Michael Pearson sold a lot of his stock in the company and short seller Andrew Left called the stock an "obvious zero."
Dennis Gartman, "The Gartman Letter" editor and publisher, discusses why he's reversing his views on oil.
The "Fast Money" traders discuss the expectations for this earnings season and what to look in upcoming releases.
CNBC's Meg Tirrell speaks with Juno Therapeutics CEO Hans Bishop about the FDA's decision to take his company's immunotherapy trial off clinical hold.
Melissa Lee is the host of CNBC's “Fast Money” and “Options Action.”
Chief Market Strategist & Director of Advisor Advocacy, Private Advisor Group
CEO & Co-founder, Metropolitan Capital Advisors
Director of Institutional Sales Stuart Frankel & Co. Inc.
Founder and Managing Member, Brian Kelly Capital LLC
Co-Founder Najarian Family Office and Najarian Advisors
Co-Founder, Najarian Family Office and Najarian Advisors
Co-Founder and Editor, RiskReversal.com
Managing Partner, Triogem Asset Management, Founder, EmergingMoney.com